Navigation Links


Dubin in Medical News

Martek Announces Second Quarter 2009 Financial Results

...compared with $9.2 million, or $0.28 per diluted share, in last year's second quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "The continued execution of our business plan allowed Martek to generate record revenues and profits in the second quarter. These results were a...

Missouri Behavioral Pharmacy Management Program Receives 2008 SAMHSA Science and Service Award

...08 Science and Service Award Winners, October 22, 2008 News Release. http://www.samhsa.gov/newsroom/advisories/0810222125.aspx . (2) Ning A, dubin WR, Parks JJ. Pharmacy costs: Finding a role for quality. Psychiatric Services, 2005; 56:909-11. ...

Martek Announces First Quarter 2008 Financial Results

... 2008 compared with $2.8 million, or $0.08 per diluted share, in last year's first quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "The results for the first quarter show a solid start to fiscal 2008 and reflect our continued execution of our business plan. During the first ...

Martek Announces Third Quarter 2007 Financial Results

...share, compared with $4.6 million, or $0.14 per diluted share, in last year's third quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "Martek's improved financial performance this quarter resulted from growth in both sales of DHA for uses other than infant formula and sales of ...
Dubin in Medical Dictionary

Dubin

Dubin is a village in the administrative district of Gmina Jutrosin, within Rawicz County, Greater Poland Voivodeship, in west-central Poland. It lies approximately 5 kilometres (3 mi) south-west of Jutrosin, 20 km (12 mi) east of Rawicz, and 89 km (55 mi) south of the... Dubin Residential ...

Dubin-Johnson syndrome

... dubin - Johnson syndrome is an autosomal recessive ...ith a defect in the ability of hepatocytes... dubin - Johnson Syndrome information including sympto...s, videos, forums, prevention, and prognosis. dubin - Johnson syndrome symptoms, causes, diagnosis,...
Dubin in Biological Technology

Martek Announces First Quarter 2009 Financial Results

...09 compared with $8.7 million, or $0.26 per diluted share, in last year's first quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "Despite the troubling economy, Martek's first quarter results showed both revenue and bottom line growth reflecting the strength of our core in...

Martek Announces Fourth Quarter and FY 2008 Financial Results

... a 17% increase. (see "Reconciliation of GAAP to Non-GAAP Net Income Measure" below). Commenting on the quarter, Chief Executive Officer Steve dubin said, "Our results in this year's fourth quarter as well as the full fiscal year 2008 reflect the continued execution of our business plan. During the...

Martek Announces Third Quarter 2008 Financial Results

...p 47% compared with $6.1 million, or $0.19 per diluted share, in last year's third quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "Martek's third quarter was another solid quarter for the Company reflecting revenues and earnings in excess of our projections as well as the c...

Daniel B. Dubin, M.D., Joins NanoBio Corp.'s Board of Directors

...l B. Dubin, M.D., to its board of directors. Dr. dubin currently serves as Vice Chairman and a Director a...nfections." A Harvard-trained dermatologist, Dr. dubin served as Ambulatory Medical Director of the derma...tice at Brigham and Women's Hospital. In 1996, Dr. dubin co-founded MEDACorp to provide life science compan...

Martek Announces Second Quarter 2008 Financial Results

...2008 compared with $4.9 million, or $0.15 per diluted share, in last year's second quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "Martek's strong second quarter results reflect the continued execution of the Company's business plan. Martek's core infant formula business gr...

Martek Announces Fourth Quarter and FY 2007 Financial Results

...and 2006, respectively (see "Reconciliation of GAAP to Non-GAAP Net Income Measure" below). Commenting on the quarter, Chief Executive Officer Steve dubin said, "Our results in this year's fourth quarter confirm that our strategies are on target and demonstrate the progress we have made against our key f...
Other TagsVariableManifoldQIAvacThermometer
(Date:5/23/2012)... WEDNESDAY, May 23 (HealthDay News) -- The use ... reduced through a multi-pronged approach that includes more ... relatives, according to a new German study. ... ineffective, physical restraints such as bed rails and ... A recent survey found that the rate of ...
(Date:5/23/2012)... in the United Kingdom have determined that azithromycin, ... can be an effective treatment option for patients ... complication that occurs in the majority of patients ... leading cause of mortality after the first year ... body repeatedly rejects the transplanted lung tissue. The ...
(Date:5/22/2012)... randomized controlled trials (RCTs) are critical for determining ... Canada provides scant support for these studies compared ... CMAJ ( Canadian Medical Association Journal ... Hamilton Health Sciences, Hamilton, Ontario, with Dr. John ... analysis and appendix that Canada should provide better ...
(Date:5/22/2012)... The uproar that began last year when the U.S. ... longer offer regular prostate-cancer tests to healthy men continued ... report. Overall, they stuck to their guns, stating that ... cancer, the PSA test, causes more harm than good ... even dangerous, treatments. , But many people simply don,t ...
(Date:5/22/2012)... By Maureen Salamon HealthDay Reporter , , ... U.S. advisory panel no longer recommends that men ... blood test, men should ask their doctors for ... experts say. Urologists and cancer experts dismissed ... Force,s criticism of the PSA test will set ...
Breaking Medicine News(10 mins):Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Canada should significantly increase its funding of randomized clinical trials 2Health News:Psychological Science explains uproar over prostate-cancer screenings 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 3
(Date:5/23/2012)... at the University of British Columbia and the Smithsonian ... that coordinates its signature lunge-feeding behaviour and may ... a subgroup of baleen whales including blue, fin, ... special, accordion-like blubber layer that goes from the snout ... times its resting length to allow the whales to ...
(Date:5/23/2012)... from Boston University School of Medicine (BUSM) shows ... preferences for social, spiritual and political behaviors. The ... issue of Genetic Syndromes and Gene Therapy ... may predict presidential outcomes more than the actual ... , This research was reported by Marlene Oscar ...
(Date:5/23/2012)... The launch of a new centre of North Sea ... accelerate development of carbon capture and storage (CCS) and ... North Sea worth 190 billion. , The Centre ... will develop understanding of enhanced oil recovery (EOR) technology, ... power plants and industry. , The Centre is ...
Breaking Biology News(10 mins):A whale of a discovery: New sensory organ found in rorqual whales 2Study finds voter genetics may predict election outcomes 2Center for North Sea oil expertise set to boost jobs and growth 2Center for North Sea oil expertise set to boost jobs and growth 3Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 1Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 1DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 2DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 4Weill Cornell Institute for Geriatric Psychiatry awarded 2410 million grant 58274 1Weill Cornell Institute for Geriatric Psychiatry awarded 2410 million grant 58274 2Weill Cornell Institute for Geriatric Psychiatry awarded 2410 million grant 58274 3Weill Cornell Institute for Geriatric Psychiatry awarded 2410 million grant 58274 4
Other Contentsbundlebundlebundlebundlebundlebundlebundledeferensdeferensvasvasvasbundlesbundlesbundlesbundlesbundlesbundlesplantsplantsplantsplantsplantsplantsplantscambiumvascularvascularvascularvascularvascularvascularvascularvascularvascularvectorsvectorsvectorsvectorsvectorsvectors